Guardion Health Sciences, Inc.
GHSI · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | $0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 10.8% | 52.8% | 282.7% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 44% | 40.9% | 43% | -3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -32% | -55% | -134.1% | -441.6% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 1.3% | -274% | -342.1% | -453.9% |
| EPS Diluted | 0.12 | -27.01 | -52.23 | -180.53 |
| % Growth | 100.4% | 48.3% | 71.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |